Cellular Oncology

Article	Citations
Angiogenesis as a hallmark of solid tumors - clinical perspectives	132
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities	76
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN	75
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance	54
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications	52
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma	51
A comprehensive review of SHP2 and its role in cancer	47
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis	39
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities	38
HDAC6: A unique HDAC family member as a cancer target	35
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment	34
Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma	33
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers	30
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer	29
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells	28
Protein arginine methyltransferase 5: a potential cancer therapeutic target	28
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing	28
How VEGF-A and its splice variants affect breast cancer development – clinical implications	26
Clinical perspectives of BET inhibition in ovarian cancer	26
The Duchenne muscular dystrophy gene and cancer	26
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin	26
Circular RNA circNFATC3 acts as a miR-9-5p sponge to promote cervical cancer development by upregulating SDC2	25
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer	25
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy	25
Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications	23

Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation	23
Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis	22
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening	22
Cancer‐associated fibroblasts secrete hypoxia‐induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway	22
Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression	21
Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma	20
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models	20
LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway	19
3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment	19
Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging	19
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer	18
Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress	18
Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction	18
Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer	18
Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer	18
RETRACTED ARTICLE: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling	18
Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer	17
Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel	17
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling	17
RETRACTED ARTICLE: Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis	17
Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity	17
Long non‐coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p	17
The impact of mitochondria on cancer treatment resistance	17
Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation	17
Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A	16
Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia	16
IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer	16
Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor	16
Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach	16
The role of pyroptosis in hepatocellular carcinoma	15
In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer	15
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer	15
Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination	15
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation	15
Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion	15
1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas	15
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway	14
Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA	14
Organoid technology for personalized pancreatic cancer therapy	14
UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells	14
LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca2+ concentration via transcription factor GATA6	14
SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α	13
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition	13
The application of patient-derived organoid in the research of lung cancer	13
BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways	13
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer	12
Crosstalk between long noncoding RNA and microRNA in Cancer	12
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer	12
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy	12
Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway	12

Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection	12
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS	12
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression	12
DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets	12
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma	12
GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer	11
NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells	11
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer	11
IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression	11
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models	11
Role of ELMO1 in inflammation and cancer—clinical implications	10
Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κB	10
Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial–mesenchymal transition through targeting major vault protein (MVP)	10
Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma	10
Soluble TGFBI aggravates the malignancy of cholangiocarcinoma through activation of the ITGB1 dependent PPARγ signalling pathway	10
Distinct tumor microenvironment landscapes of rectal cancer for prognosis and prediction of immunotherapy response	10
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer	10
YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models	10
Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis	10
Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer	10
The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis	10
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression	10
Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer	10
PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer	10
Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non‐transformed skeletal muscle cells	9
Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway	9
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma	9
Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer	9
Cystatin F acts as a mediator of immune suppression in glioblastoma	9
Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance	9
Spheroid-induced heterogeneity and plasticity of uveal melanoma cells	9
Involvement of ACACA (acetyl-CoA carboxylase α) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts	9
Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells	9
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy	9
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors	9
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling	9
The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma	9
Contribution of mechanical homeostasis to epithelial-mesenchymal transition	9
H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis	8
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non‐medullary thyroid cancer	8
Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux	8
Glioblastoma, from disease understanding towards optimal cell-based in vitro models	8
FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling	8
EV-miRome-wide profiling uncovers miR-320c for detecting metastatic colorectal cancer and monitoring the therapeutic response	8
RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma	8
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models	8
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation	8
Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8+ T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma	8
The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth	8
ACSM3 suppresses the pathogenesis of high-grade serous ovarian carcinoma via promoting AMPK activity	8
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis	8
MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer	8
Molecular changes in adipocyte-derived stem cells during their interplay with cervical cancer cells	7
Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization	7
Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma	7
Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma	7
CDK7 blockade suppresses super‐enhancer‐associated oncogenes in bladder cancer	7
PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth	7
Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures	7
Iron metabolism in colorectal cancer: a balancing act	7
Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors	7
Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis	7
Application of circulating tumour cells to predict response to treatment in head and neck cancer	7
Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models	7
Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation	7
Calcium acts as a central player in melatonin antitumor activity in sarcoma cells	7
The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options	7
The ceramide synthase (CERS/LASS) family: Functions involved in cancer progression	7
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities	7
MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway	7
Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition	6
YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m6A-mediated YWHAZ stability	6
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models	6
Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects	6
Methionine-producing tumor micro(be) environment fuels growth of solid tumors	6
circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53	6
Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway	6
CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer	6
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma	6
PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer	6

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis	6
CEP55 3’-UTR promotes epithelial–mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p	6
Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma	6
PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway	5
YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma	5
Chronic exercise training attenuates prostate cancer-induced molecular remodelling in the testis	5
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells	5
In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)	5
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells	5
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells	5
Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition	5
Targeting tumor-intrinsic PD-L1 suppresses the progression and aggressiveness of head and neck cancer by inhibiting GSK3β-dependent Snail degradation	5
Roles of NRF2 in DNA damage repair	5
Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics	5
PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity	5
SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans	5
Drug combination screening as a translational approach toward an improved drug therapy for chordoma	5
LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder	5
Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer	5
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer	5
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy	5
TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling	5
Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation	5
RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis	5
Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?	5
Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines	5
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2	5
Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression	5
TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8+ T cells in hepatocellular carcinoma	5
Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution	5
Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination	5
Functional relationship between CFTR and RAC3 expression for maintaining cancer cell stemness in human colorectal cancer	5
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism	5
Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth	4
Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer	4
SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma	4
miR-4739 promotes epithelial-mesenchymal transition and angiogenesis in “driver gene-negative” non-small cell lung cancer via activating the Wnt/β-catenin signaling	4
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer	4
Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer	4
Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK	4
Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling	4
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway	4
The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cells	4
Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry	4
Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers	4
Circulating tumour cell isolation, analysis and clinical application	4
Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer	4
The changing microRNA landscape by color and cloudiness: a cautionary tale for nipple aspirate fluid biomarker analysis	4
Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer	4
Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function	4
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis	4
Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway	4
A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis	4
Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer	4
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma	4
Ferritinophagy induced ferroptosis in the management of cancer	4
COX2 confers bone marrow stromal cells to promoting TNFα/TNFR1β-mediated myeloma cell growth and adhesion	4
Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner	4
MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer	4
Altered iron metabolism as a target for ferroptosis induction in head and neck cancer	4
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia	4
The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma	4
Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer	4